Sulfonamide compounds for the treatment of respiratory disorders

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Pulmagen Theraputics (Inflammation) Limited patent solves the following problem:

A broad spectrum of respiratory diseases and disorders recognized and many of which have overlapping and interacting etiologies. Two of the most common and widespread of these diseases are chronic obstructive pulmonary disorder (COPD) and asthma. Respiratory diseases have a significant inflammatory component. For example, the current therapy for COPD and asthma focused mainly on reducing symptoms in short and long acting bronchodilators either as monotherapies or in combination with long-acting 2 agonist bronchodilators with inhaled corticosteroids (ICS ).

Our analysis of this patent is as follows:

Pulmagen Theraputics (Inflammation) Limited’s patent US 8362064 B2 deals with Sulfonamide compounds for the treatment of respiratory disorders.
Compounds of formula (I) are agonists of PPAR, useful for the treatment of respiratory diseases; formula (I): wherein R1, R2 or P3 each independently represents halo, cyano, nitro, amino, alkyl, haloalkyl, alkoxy, haloalkoxy, carboxylic acid or an ester or amide thereof; R4 represents hydrogen or alkyl; m, nop independently represents 0, 1, 2 or 3.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Pyrazole derivatives used as CCR4 receptor antagonists

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Glaxo Group Limited patent solves the following problem:

Chemokines are believed to play an important role in immune and inflammatory responses in a number of diseases or conditions of the CC-chemokine receptor 4 (CCR4) original clone from a basophilic cell line (Power et al, J. Biol. Chem.; 270: 19495: 1995). The small molecule CCR4 receptor antagonists known in the art, with examples that described in Andrews et al (mol Pharmacol 73: 855, 2008).

Our analysis of this patent is as follows:

Glaxo Group Limited’s patent US 8357716 B2 deals with Pyrazole derivatives used as CCR4 receptor antagonists.
Indazole compounds, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing such compounds and their use in therapy.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Devices and methods for reducing vehicle drag

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The SmartTruckSystems, LLC patent solves the following problem:

An ongoing effort to reduce the drag in vehicular structures is of great importance as the fuel economy will be a greater consideration in vehicular design. As the drag of a car increases, the amount of fuel needed to move vehicles also increased because of greater energy required to overcome drag. For example, it states that for a vehicle traveling at 70 mph, 65% of the total fuel consumption of the engine of the car used to overcome drag. Therefore, even a small reduction in drag experienced by a vehicle traveling at a speed of course would result in a significant improvement in fuel economy.

Our analysis of this patent is as follows:

SmartTruckSystems, LLC’s patent US 8342595 B2 deals with Devices and methods for reducing vehicle drag.
An apparatus for reducing drag in a trailer provided. The apparatus may further include a pair of fairings configured positions on opposite sides of a trailer in front of the wheels under a trailer, a pair of fairings configured positions on opposite sides in a trailer behind the wheel under a trailer, with two pairs of fairings placed and shaped to direct the air smoothly around the wheels and wheel and through the center of the trailer. The apparatus may also include a ramp in front of the suspension components, aerodynamically shaped wings on the axles, and a rear diffuser, these components are configured to direct air orderly among the trailer suspension and the earth. The high command of the wind energy from facilities results in a reduction in trailer base drag.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.